Page last updated: 2024-08-24

lonapalene and arachidonic acid

lonapalene has been researched along with arachidonic acid in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Black, AK; Camp, RD; Cunningham, FM; Greaves, MW; Hofbauer, M; Mallet, AI1
Calhoun, W; Carlson, RP; Chang, JY; Datko, L; Kreft, AF; Musser, JH; O'Neill-Davis, L1
Gibert, C; Moragas, JM; Puig, L; Solá, J; Vila, L1
Berks, AH; Jones, GH; Kruseman, M; Loe, BE; Maloney, PJ; Murthy, DV; Simpson, RA; Spires, DA; Venuti, MC; Young, JM1
Jones, GH; Loe, BE; Venuti, MC; Young, JM1
Fogh, K; Herlin, T; Iversen, L; Kragballe, K1

Trials

1 trial(s) available for lonapalene and arachidonic acid

ArticleYear
Pharmacologic and clinical effects of lonapalene (RS 43179), a 5-lipoxygenase inhibitor, in psoriasis.
    The Journal of investigative dermatology, 1990, Volume: 95, Issue:1

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adult; Arachidonate Lipoxygenases; Arachidonic Acid; Arachidonic Acids; Chromatography, High Pressure Liquid; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Lipoxygenase Inhibitors; Male; Middle Aged; Naphthalenes; Psoriasis

1990

Other Studies

5 other study(ies) available for lonapalene and arachidonic acid

ArticleYear
Effect of a 5-lipoxygenase (5-LO)/cyclooxygenase (CO) inhibitor, WY-47, 288, on cutaneous models of inflammation.
    Agents and actions, 1989, Volume: 26, Issue:3-4

    Topics: Animals; Arachidonate Lipoxygenases; Arachidonic Acid; Arachidonic Acids; Cyclooxygenase Inhibitors; Disease Models, Animal; Ear; Erythema; Female; Guinea Pigs; Inflammation; Lipoxygenase Inhibitors; Mice; Naphthalenes; Quinolines; Radiation Injuries; Salicylates; Skin; Skin Diseases; Tetradecanoylphorbol Acetate; Ultraviolet Rays

1989
Effect of lonapalene on metabolism of exogenous arachidonic acid in human platelets.
    Skin pharmacology : the official journal of the Skin Pharmacology Society, 1989, Volume: 2, Issue:2

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Chromatography, High Pressure Liquid; Eicosanoids; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Lipoxygenase; Naphthalenes; Prostaglandin-Endoperoxide Synthases

1989
Topical nonsteroidal antipsoriatic agents. 1. 1,2,3,4-Tetraoxygenated naphthalene derivatives.
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:8

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Topical; Animals; Arachidonate Lipoxygenases; Arachidonic Acid; Arachidonic Acids; Biological Assay; Edema; Female; Humans; Lipoxygenase Inhibitors; Mice; Naphthalenes; Neutrophils; Ornithine Decarboxylase Inhibitors; Oxygen; Psoriasis; Structure-Activity Relationship; Tetrahydronaphthalenes

1986
Topical nonsteroidal antipsoriatic agents. 2. 2,3-(Alkylidenedioxy)naphthalene analogues of lonapalene.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:11

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arachidonic Acids; Edema; Mice; Naphthalenes; Psoriasis; Structure-Activity Relationship

1988
Modulation of eicosanoid formation by lesional skin of psoriasis: an ex vivo skin model.
    Acta dermato-venereologica, 1993, Volume: 73, Issue:3

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Arachidonic Acid; Calcimycin; Chromatography, High Pressure Liquid; Dinoprostone; Eicosanoids; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Leukotriene B4; Lipoxygenase Inhibitors; Naphthalenes; Psoriasis; Radioimmunoassay; Skin

1993